Pharmacy intern provisions modifications
SF3121 makes several changes to Minnesota’s pharmacy intern laws and related Board of Pharmacy fee and renewal provisions. The bill expands the statutory definition of “pharmacist intern” to expressly include certain residency and fellowship participants, including some licensed pharmacists from other states, ACPE-accredited pharmacy graduates not otherwise registered as interns, and certain foreign pharmacy graduates seeking internship experience. It also lowers the pharmacy intern application fee from $75 to $25 and sets the annual renewal fee at $25 beginning January 1, 2026.
The bill revises intern registration and renewal rules to create a more detailed annual renewal process, including a September 30 expiration date, a September 1 renewal deadline, late fees, and requirements for employment notices, progress affidavits, and continued pursuit of a pharmacy degree, residency, or fellowship. It also clarifies when the Board must terminate an intern registration if the person is no longer enrolled in an accredited pharmacy program, and it allows certain late or reinstated applications to receive a prorated extension in limited circumstances. In addition, the bill codifies the 1,600-hour internship requirement for pharmacist licensure and the limits on how those hours may be earned.
The bill’s impact on state law is to amend Minnesota Statutes sections 151.01, 151.065, and 151.101 governing pharmacy interns, fees, renewals, and licensure prerequisites, while also repealing outdated Minnesota Rules provisions that duplicate or conflict with the new statutory language. It would affect pharmacy students, interns, residency and fellowship participants, foreign pharmacy graduates, and the Board of Pharmacy by changing who may qualify as an intern and how intern registrations are maintained and renewed.
Overall sentiment appears neutral to favorable based on the bill’s structure and lack of recorded opposition, though no committee transcript or vote history is available in the provided materials. The bill seems aimed at modernizing and clarifying intern pathways while reducing the fee burden for interns. Potential points of contention would likely center on the broader eligibility categories for intern status, the administrative requirements for renewal, and whether the reduced fee and new renewal rules appropriately balance access with oversight.
SF3121 amends Minnesota’s pharmacy practice statutes to broaden the definition of pharmacist intern, reduce intern fees, and create more specific registration, renewal, lapse, and reinstatement rules. It also codifies internship hour requirements for pharmacist licensure and repeals outdated administrative rules that covered the same subject matter. The bill primarily affects pharmacy interns, pharmacy students, residency and fellowship participants, foreign pharmacy graduates, and the Minnesota Board of Pharmacy.
No committee testimony or vote record is provided, so there is no documented public debate to gauge. Based on the bill text alone, the measure appears generally supportive of pharmacy trainees and administrative clarity, with a likely favorable reception because it lowers fees and recognizes additional training pathways. The absence of recorded opposition suggests no clear controversy in the available materials, though that cannot be confirmed from the provided record.
The main issues that could draw scrutiny are the expanded definition of who counts as a pharmacy intern, especially residency/fellowship participants and foreign pharmacy graduates, and the new renewal compliance requirements tied to employment notices, affidavits, and continued enrollment or training. Another possible point of debate is the reduction in intern fees, which benefits applicants but could be viewed as reducing board revenue. No specific opposing viewpoints, amendments, or recorded votes are included in the provided materials.